Association between Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4) Locus and Early-Onset Anti-acetylcholine Receptor-Positive Myasthenia Gravis in Serbian Patients-Reference-Cited by-同舟云学术

Association between Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4) Locus and Early-Onset Anti-acetylcholine Receptor-Positive Myasthenia Gravis in Serbian Patients

Published:2024-04-23 Issue: Volume: Page:
ISSN:0893-7648
Container-title:Molecular Neurobiology
language:en
Short-container-title:Mol Neurobiol

Author:

Djordjevic Ivana,Garai Nemanja,Peric Stojan,Karanovic Jelena,Pesovic Jovan,Brkusanin Milos,Lavrnic Dragana,Apostolski Slobodan,Savic-Pavicevic Dusanka,Basta Ivana

Funder

Ministry of science, Technological Development and Innovations of the Republic of Serbia

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12035-024-04183-8.pdf

Reference51 articles.

1. Lazaridis K, Tzartos SJ (2020) Autoantibody specificities in myasthenia gravis; implications for improved diagnostics and therapeutics. Front Immunol 11:212. https://doi.org/10.3389/fimmu.2020.00212

2. Bubuioc AM, Kudebayeva A, Turuspekova S, Lisnic V, Leone MA (2021) The epidemiology of myasthenia gravis. J Med Life 14(1):7–16. https://doi.org/10.25122/jml-2020-0145

3. Lavrnic D, Basta I, Rakocevic-Stojanovic V et al (2013) Epidemiological study of adult-onset myasthenia gravis in the area of Belgrade (Serbia) in the period 1979–2008. Neuroepidemiology 40(3):190–194. https://doi.org/10.1159/000342777

4. Chia R, Saez-Atienzar S, Murphy N et al (2022) Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study. Proc Nat Acad Sci USt Am 119(5):e2108672119. https://doi.org/10.1073/pnas.2108672119

5. Gregersen PK, Kosoy R, Lee AT et al (2012) Risk for myasthenia gravis maps to a (151) Pro–>Ala change in TNIP1 and to human leukocyte antigen-B*08. Ann Neurol 72(6):927–935. https://doi.org/10.1002/ana.23691